BusinessVBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at SITC 2017By Nasdaq OMXNov 10, 2017, 1:00 PM UTC
BusinessOmniSeq Receives CAP Accreditation and Publishes Analytical Validation PaperBy Nasdaq OMXNov 9, 2017, 1:02 PM UTC
BusinessMerus to Present at the Jefferies London Healthcare ConferenceBy Nasdaq OMXNov 9, 2017, 12:30 PM UTC
BusinessOncoMed Announces Third Quarter 2017 Financial Results and Operational HighlightsBy Nasdaq OMXNov 2, 2017, 8:06 PM UTC
BusinessRitter Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business UpdateBy Nasdaq OMXOct 31, 2017, 10:45 AM UTC
BusinessFluidigm Introduces Imaging Mass Cytometry System for Highly Multiplexed Protein Detection in TissuesBy Nasdaq OMXOct 24, 2017, 12:01 PM UTC
BusinessNovel Preclinical Research Tools Provide Humanized Immune Response to Advance Immunotherapeutic Development, Live Webinar Hosted by Crown BioscienceBy Nasdaq OMXOct 19, 2017, 12:00 PM UTC
BusinessCrown Bioscience to Showcase Scientific Expertise in Preclinical Evaluation of Investigational Cancer Compounds at the American Association for Cancer Research’s International Conference on Molecular Targets and Cancer TherapeuticsBy Nasdaq OMXOct 17, 2017, 1:51 PM UTC
